Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
100%
Jews
48%
Ashkenazi
43%
BRCA2
36%
Ashkenazi Jews
30%
Breast Reconstruction
30%
Colon Cancer Cells
27%
Tumor
26%
High-risk Women
24%
Growth Factors
24%
Liver
22%
Thromboangiitis Obliterans
22%
Breast
22%
Jewish Women
21%
Hepatocytes
20%
Extracellular Matrix
20%
BRCA mutation
19%
High Risk
18%
Breast Cancer Patients
18%
Hypothyroidism
18%
Mutation Carriers
17%
Breast Cancer Risk
17%
Tumor Necrosis Factor-α
16%
Familial Breast Cancer
16%
Inherited Predisposition
15%
Israel
15%
Buerger's Disease
14%
Insulin-like
14%
Breast Carcinoma
14%
Bleeding
14%
Germline mutation
14%
Tyrosine Phosphorylation
13%
BRCA2 mutation
13%
SHEBA
13%
Stopped Flow
13%
Laparoscopic Sleeve Gastrectomy
13%
Insulin
13%
Magnetic Resonance-guided Focused Ultrasound Surgery
13%
Cardiac Magnetic Resonance Imaging (cMRI)
13%
Non-carriers
13%
Polymorphism
13%
ERBB2
13%
Lumpectomy
13%
Ovarian Cancer
12%
Ablation
11%
Breast Biopsy
11%
Neoadjuvant Chemotherapy
11%
185delAG
11%
Mastectomy
10%
Breast/ovarian Cancer
10%
Medicine and Dentistry
Breast Cancer
67%
Neoplasm
33%
Quadrantectomy
20%
Tumor
18%
Diseases
18%
Bleeding
16%
Neoadjuvant Chemotherapy
15%
Reoperation
13%
Obliterating Endarteritis
13%
Laparoscopic Sleeve Gastrectomy
13%
Ultrasound Surgery
13%
Breast Carcinoma
13%
Lumpectomy
12%
Magnetic Resonance Imaging
12%
BRCA1
12%
Infection
12%
Mastectomy
11%
Breast Biopsy
11%
Breast Surgery
10%
Morbidity
10%
Melanoma
10%
Sentinel Node
9%
Liver Injury
9%
Recurrent Disease
9%
Cancer
9%
Disease Predisposition
9%
Metastatic Melanoma
9%
Surgical Anastomosis
9%
Carcinoid
9%
Sleeve Gastrectomy
9%
Chemoprophylaxis
9%
Preventive Mastectomy
9%
Cell Therapy
9%
Hypothyroidism
9%
Retroperitoneal Lymph Node Dissection
8%
Awareness
8%
BRCA2
8%
Malignant Neoplasm
8%
Primary Tumor
8%
Sentinel Lymph Node
7%
General Anesthesia
7%
Heparin
6%
Interleukin 2
6%
Chemotherapy
6%
Biopsy Technique
6%
Surgeon
6%
Neoadjuvant Therapy
6%
Symptomatic Treatment
6%
Ovarian Cancer
5%
Surgical Margin
5%